688389 Stock Overview
Shenzhen Lifotronic Technology Co., Ltd. develops, manufactures, and markets medical devices for diagnostic and therapeutic purposes in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Shenzhen Lifotronic Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.27 |
| 52 Week High | CN¥27.52 |
| 52 Week Low | CN¥14.00 |
| Beta | 0.40 |
| 1 Month Change | 3.88% |
| 3 Month Change | 16.93% |
| 1 Year Change | -26.03% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688389 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.5% | 6.0% | 4.2% |
| 1Y | -26.0% | -13.9% | -13.2% |
Return vs Industry: 688389 underperformed the CN Medical Equipment industry which returned -13.9% over the past year.
Return vs Market: 688389 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 688389 volatility | |
|---|---|
| 688389 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688389 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688389's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,481 | Ming Long Hu | www.lifotronic.com |
Shenzhen Lifotronic Technology Co., Ltd. develops, manufactures, and markets medical devices for diagnostic and therapeutic purposes in China. The company offers IVD products, such as HPLC systems, including hemoglobin and HbA1c analyzers, ECLIA systems comprising automated ECL immunoassay analyzers; hematology analyzers; POCT, such as immunofluorescence analyzers; molecular diagnostics, including automated nucleic acid purification system and real-time PCR systems; and rapid tests for COVID-19, malaria, dengue, and influenza A and B. It also provides therapeutic products comprising respiratory and ICU products, such as video laryngoscope, warmer unit with disposable blanket, high-flow humidification systems, high frequency chestwall oscillation, and intermittent pneumatic compression pumps; wound care products, including negative pressure wound therapy, ultrasound-assisted wound debridement, and wound healing light therapy; and ESWT pain management products comprising electromagnetic shockwave and extracorporeal shock wave therapy. In addition, the company’s medical and aesthetic laser products comprises of intensive pulse light, fractional CO2 laser systems, Q-switched Nd:YAG laser systems, and fiber laser hair removal systems.
Shenzhen Lifotronic Technology Co., Ltd. Fundamentals Summary
| 688389 fundamental statistics | |
|---|---|
| Market cap | CN¥8.25b |
| Earnings (TTM) | CN¥347.69m |
| Revenue (TTM) | CN¥1.17b |
23.7x
P/E Ratio7.0x
P/S RatioIs 688389 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688389 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.17b |
| Cost of Revenue | CN¥410.16m |
| Gross Profit | CN¥763.50m |
| Other Expenses | CN¥415.81m |
| Earnings | CN¥347.69m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 65.05% |
| Net Profit Margin | 29.62% |
| Debt/Equity Ratio | 11.2% |
How did 688389 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield35%
Payout RatioDoes 688389 pay a reliable dividends?
See 688389 dividend history and benchmarks| Shenzhen Lifotronic Technology dividend dates | |
|---|---|
| Ex Dividend Date | May 06 2024 |
| Dividend Pay Date | May 06 2024 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 4 days |
Does 688389 pay a reliable dividends?
See 688389 dividend history and benchmarks